Compare IOVA & BLSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IOVA | BLSH |
|---|---|---|
| Founded | 2007 | 2020 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 5.8B |
| IPO Year | 2008 | 2021 |
| Metric | IOVA | BLSH |
|---|---|---|
| Price | $7.41 | $19.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 14 |
| Target Price | $14.50 | ★ $36.15 |
| AVG Volume (30 Days) | ★ 12.8M | 1.5M |
| Earning Date | 11-05-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $58.86 | $49.48 |
| Revenue Next Year | $41.86 | $12.47 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.08 | $18.80 |
| 52 Week High | $15.37 | $48.93 |
| Indicator | IOVA | BLSH |
|---|---|---|
| Relative Strength Index (RSI) | 31.10 | 32.55 |
| Support Level | $3.57 | N/A |
| Resistance Level | $9.36 | $25.01 |
| Average True Range (ATR) | 0.57 | 1.69 |
| MACD | -0.13 | -0.10 |
| Stochastic Oscillator | 4.34 | 11.35 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
Bullish is an institutionally focused global digital asset platform focused on providing market infrastructure and information services. Its objective is to provide mission critical products and services that are designed to help institutions grow their businesses, empower individual investors, and drive the adoption of stablecoins, digital assets, and blockchain technology. It expanded its product offering to provide trusted insights, authoritative news, data, indices and transparent analysis to the digital assets industry while facilitating partnerships, investment opportunities, and community engagement through its flagship Consensus conference.